Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)

Market Cap	706.82M -32.3%
Revenue (ttm)	975.55M -9.5%
Net Income	93.25M +21.3%
EPS	0.10 +23.2%
Shares Out	n/a
PE Ratio	7.58
Forward PE	6.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,500
Open	0.72175
Previous Close	n/a
Day's Range	0.72175 - 0.7500
52-Week Range	0.7190 - 1.0800
Beta	0.12
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 21, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,658
• Stock Exchange: OTCMKTS
• Ticker Symbol: GNMLF

Financial Performance

In 2025, Genomma Lab Internacional's revenue was 17.54 billion, a decrease of -5.73% compared to the previous year's 18.61 billion. Earnings were 1.61 billion, an increase of 8.10%.

Financial numbers in MXN

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 25, 2026

Data Sources Report a data error